|
1
|
Kew MC: Epidemiology of chronic hepatitis
B virus infection, hepatocellular carcinoma, and hepatitis B
virus-induced hepatocellular carcinoma. Pathol Biol (Paris).
58:273–277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nguyen VT, Law MG and Dore GJ: Hepatitis
B-related hepatocellular carcinoma: Epidemiological characteristics
and disease burden. J Viral Hepat. 16:453–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun VC and Sarna L: Symptom management in
hepatocellular carcinoma. Clin J Oncol Nurs. 12:759–766. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 4:5–13.
2010. View Article : Google Scholar
|
|
7
|
Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ and
Wu F: Solitary large hepatocellular carcinoma: A specific subtype
of hepatocellular carcinoma with good outcome after hepatic
resection. Ann Surg. 249:118–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu AX, Duda DG, Sahani DV and Jain RK:
HCC and angiogenesis: Possible targets and future directions. Nat
Rev Clin Oncol. 8:292–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herranz H and Cohen SM: MicroRNAs and gene
regulatory networks: Managing the impact of noise in biological
systems. Genes Dev. 24:1339–1344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qu Z, Wu J, Wu J, Ji A, Qiang G, Jiang Y,
Jiang C and Ding Y: Exosomal miR-665 as a novel minimally invasive
biomarker for hepatocellular carcinoma diagnosis and prognosis.
Oncotarget. 8:80666–80678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu L, Chen J, Liu Y, Zhang Z and Duan S:
MicroRNA-937 inhibits cell proliferation and metastasis in gastric
cancer cells by downregulating FOXL2. Cancer Biomark. 21:105–116.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li G, Wu F, Yang H, Deng X and Yuan Y:
MiR-9-5p promotes cell growth and metastasis in non-small cell lung
cancer through the repression of TGFBR2. Biomed Pharmacother.
96:1170–1178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X and Wu X: The Role of
MicroRNA-1207-5p in colorectal cancer. Clin Lab. 63:1875–1882.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: MicroRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Hu G and Zhou J: Repression of
versican expression by microRNA-143. J Biol Chem. 285:23241–23250.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang
L, Huang D, Tan C, Sheng W and Du X: Plasma miR-601 and miR-760 are
novel biomarkers for the early detection of colorectal cancer. PLoS
One. 7:e443982012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu JY, Yi W, Wei X, Zhang MY, Xu R, Zeng
LS, Huang ZJ and Chen JS: miR-601 is a prognostic marker and
suppresses cell growth and invasion by targeting PTP4A1 in breast
cancer. Biomed Pharmacother. 79:247–253. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao W, Jin H, Zhang L, Chen X and Qian H:
Identification of miR-601 as a novel regulator in the development
of pancreatic cancer. Biochem Biophys Res Commun. 483:638–644.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qiao CX, Zhai XF, Ling CQ, Lang QB, Dong
HJ, Liu Q and Li MD: Health-related quality of life evaluated by
tumor node metastasis staging system in patients with
hepatocellular carcinoma. World J Gastroenterol. 18:2689–2694.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao G, Dong W, Meng X, Liu H, Liao H and
Liu S: MiR-511 inhibits growth and metastasis of human
hepatocellular carcinoma cells by targeting PIK3R3. Tumour Biol.
36:4453–4459. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu K, Li X, Cao Y, Ge Y, Wang J and Shi
B: MiR-132 inhibits cell proliferation, invasion and migration of
hepatocellular carcinoma by targeting PIK3R3. Int J Oncol.
47:1585–1593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang HD, Sun DW, Mao L, Zhang J, Jiang
LH, Li J, Wu Y, Ji H, Chen W, Wang J, et al: MiR-139-5p inhibits
the biological function of breast cancer cells by targeting Notch1
and mediates chemosensitivity to docetaxel. Biochem Biophys Res
Commun. 465:702–713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao J, Xu J and Zhang R: MicroRNA-411
inhibits malignant biological behaviours of colorectal cancer cells
by directly targeting PIK3R3. Oncol Rep. 39:633–642.
2018.PubMed/NCBI
|
|
29
|
Long XD, Huang XY, Yao JG, Liao P, Tang
YJ, Ma Y and Xia Q: Polymorphisms in the precursor microRNAs and
aflatoxin B1-related hepatocellular carcinoma. Mol Carcinog.
55:1060–1072. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu XM, Xi ZF, Liao P, Huang HD, Huang XY,
Wang C, Ma Y, Xia Q, Yao JG and Long XD: Diagnostic and prognostic
potential of serum microRNA-4651 for patients with hepatocellular
carcinoma related to aflatoxin B1. Oncotarget. 8:81235–81249.
2017.PubMed/NCBI
|
|
31
|
Liu L, Cai X, Liu E, Tian X and Tian C:
MicroRNA-18a promotes proliferation and metastasis in
hepatocellular carcinoma via targeting KLF4. Oncotarget.
8:68263–68269. 2017.PubMed/NCBI
|
|
32
|
Zhang L, Huang J, Yang N, Greshock J,
Liang S, Hasegawa K, Giannakakis A, Poulos N, O'Brien-Jenkins A,
Katsaros D, et al: Integrative genomic analysis of
phosphatidylinositol 3′-kinase family identifies PIK3R3 as a
potential therapeutic target in epithelial ovarian cancer. Clin
Cancer Res. 13:5314–5321. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang G, Yang X, Li C, Cao X, Luo X and Hu
J: PIK3R3 induces epithelial-to-mesenchymal transition and promotes
metastasis in colorectal cancer. Mol Cancer Ther. 13:1837–1847.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G,
Luo J and Ren T: MicroRNA-7-regulated TLR9 signaling-enhanced
growth and metastatic potential of human lung cancer cells by
altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt
pathway. Mol Biol Cell. 24:42–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun J and Fu L: IL-6 promotes gastric
cancer cell proliferation and EMT through regulating miR-152/PIK3R3
pathway. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 42:1241–1247.
2017.(In Chinese). PubMed/NCBI
|
|
37
|
Dong L and Hui L: HOTAIR promotes
proliferation, migration, and invasion of ovarian cancer SKOV3
cells through regulating PIK3R3. Med Sci Monit. 22:325–331. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mabuchi S, Kuroda H, Takahashi R and
Sasano T: The PI3K/AKT/mTOR pathway as a therapeutic target in
ovarian cancer. Gynecol Oncol. 137:173–179. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Asati V, Mahapatra DK and Bharti SK:
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as
anticancer agents: Structural and pharmacological perspectives. Eur
J Med Chem. 109:314–341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Samarin J, Laketa V, Malz M, Roessler S,
Stein I, Horwitz E, Singer S, Dimou E, Cigliano A, Bissinger M, et
al: PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream
element binding proteins in hepatocellular carcinoma cells.
Hepatology. 63:813–826. 2016. View Article : Google Scholar : PubMed/NCBI
|
